Incidence and risk factors for neuropsychiatric events among Ghanaian HIV patients on long-term non-nucleoside reverse transcriptase inhibitor-based therapy

Transcriptase Inhibitor ◽

Hiv Patients ◽

Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with tenofovir/emtricitabine – multicenter comparative trial vs efavirenz in naїve HIV patients

Infekcionnye bolezni ◽

10.20953/1729-9225-2017-3-5-13 ◽

2017 ◽

Vol 15 (3) ◽

pp. 5-13 ◽

Cited By ~ 1

Author(s):

A.V. Kravchenko ◽

◽

E.A. Orlova-Morozova ◽

T.E. Shimonova ◽

O.A. Kozyrev ◽

...

Keyword(s):

Reverse Transcriptase ◽

Comparative Trial ◽

Transcriptase Inhibitor ◽

Efficacy And Safety ◽

Hiv Patients ◽

Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in Cameroon

Antiviral Therapy ◽

10.3851/imp2535 ◽

2013 ◽

Vol 18 (1) ◽

pp. 29-37 ◽

Cited By ~ 16

Author(s):

Mégane Meresse ◽

◽

Maria Patrizia Carrieri ◽

Christian Laurent ◽

Charles Kouanfack ◽

...

Keyword(s):

Reverse Transcriptase ◽

Virological Response ◽

Transcriptase Inhibitor ◽

Time Patterns ◽

Very high baseline HIV viremia impairs efficacy of non-nucleoside reverse transcriptase inhibitor-based ART: a long-term observation in treatment-naïve patients

Infectious Diseases of Poverty ◽

10.1186/s40249-020-00700-8 ◽

2020 ◽

Vol 9 (1) ◽

Author(s):

Shuai Chen ◽

Yang Han ◽

Xiao-Jing Song ◽

Yan-ling Li ◽

Ting Zhu ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

High Baseline ◽

Treatment Naïve ◽

Long Term Observation ◽

Reverse Transcriptase Inhibitor ◽

Very High

PIN30 SUBSTITUTION TO LOPINAVIR/RITONAVIR (LPV/R) IS ASSOCIATED WITH IMPROVED PATIENT-REPORTED FATIGUE IN HIV+ PATIENTS EXPERIENCING SIDE EFFECTS RELATED TO THEIR PROTEASE INHIBITOR (PI)/NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI)

Value in Health ◽

10.1016/s1098-3015(10)62499-0 ◽

2004 ◽

Vol 7 (3) ◽

pp. 360

Author(s):

MP Luo ◽

Y Shen ◽

R Rode ◽

F McMillan ◽

R Tressler ◽

...

Keyword(s):

Side Effects ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Patients ◽

Patient Reported ◽

Predicted susceptibility of etravirine in HIV patients experiencing virological failure secondary to non-nucleoside reverse transcriptase inhibitor resistance in Argentina

Enfermedades Infecciosas y Microbiología Clínica ◽

10.1016/j.eimc.2011.03.003 ◽

2011 ◽

Vol 29 (6) ◽

pp. 428-431 ◽

Cited By ~ 3

Author(s):

Ezequiel Córdova ◽

Eliana Loiza ◽

Norma Porteiro ◽

Horacio Mingrone

Keyword(s):

Reverse Transcriptase ◽

Virological Failure ◽

Transcriptase Inhibitor ◽

Hiv Patients ◽

Inhibitor Resistance ◽

Long-term efficacy of dual nucleoside reverse transcriptase inhibitor antiretroviral therapy in HIV-1 infection

AIDS ◽

10.1097/00002030-200207050-00020 ◽

2002 ◽

Vol 16 (10) ◽

pp. 1432-1433 ◽

Cited By ~ 1

Author(s):

Sandro Vento ◽

Massimiliano Lanzafame ◽

Francesca Cainelli ◽

Federica Faggian ◽

Ercole Concia ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Term Efficacy ◽

Reverse Transcriptase Inhibitor ◽

Hiv 1

Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkt336 ◽

2013 ◽

Vol 69 (1) ◽

pp. 254-261 ◽

Cited By ~ 13

Author(s):

F. S. Sarfo ◽

M. A. Sarfo ◽

A. Kasim ◽

R. Phillips ◽

M. Booth ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

First Line ◽

Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

AIDS ◽

10.1097/qad.0b013e3283584500 ◽

2013 ◽

Vol 27 (1) ◽

pp. 81-85 ◽

Cited By ~ 44

Author(s):

Lourdes Anta ◽

Josep M. Llibre ◽

Eva Poveda ◽

José L. Blanco ◽

Marta Álvarez ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Resistance Mutations ◽

Hiv Patients ◽

Long-Term Efficacy of a Protease Inhibitor-Sparing, Nucleoside Reverse Transcriptase Inhibitor-Limiting Antiretroviral Regimen with Nevirapine, Lamivudine, and Reduced Standard Stavudine Dosage

HIV Clinical Trials ◽

10.1310/11pp-pg9w-fujt-64yl ◽

2004 ◽

Vol 5 (1) ◽

pp. 62-64 ◽

Cited By ~ 3

Author(s):

Shalit Peter

Keyword(s):

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Term Efficacy ◽

Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV-infected adults on a long-term non-nucleoside reverse transcriptase inhibitor-based regimen

Journal of Medical Virology ◽

10.1002/jmv.23679 ◽

2013 ◽

Vol 85 (11) ◽

pp. 1878-1882 ◽

Cited By ~ 5

Author(s):

Clotilde Allavena ◽

Audrey Rodallec ◽

Solène Sécher ◽

Véronique Reliquet ◽

Sandrine Baffoin ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Large Cohort ◽

Residual Viremia ◽

Soluble Cd14 ◽